Taj GVK Hotels & Resorts Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 30, 2025, 10:57 pm

Competitors of Taj GVK Hotels & Resorts Ltd

All Competitor Stocks of Taj GVK Hotels & Resorts Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:36 am

Below is a detailed analysis of the quarterly data for Taj GVK Hotels & Resorts Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 125.00 Cr.. The value appears to be declining and may need further review. It has decreased from 127.00 Cr. (Dec 2024) to 125.00 Cr., marking a decrease of 2.00 Cr..
• For Expenses, as of Mar 2025, the value is 92.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Dec 2024) to 92.00 Cr., marking an increase of 15.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Dec 2024) to 33.00 Cr., marking a decrease of 17.00 Cr..
• For OPM %, as of Mar 2025, the value is 27.00%. The value appears to be declining and may need further review. It has decreased from 39.00% (Dec 2024) to 27.00%, marking a decrease of 12.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 46.00 Cr. (Dec 2024) to 34.00 Cr., marking a decrease of 12.00 Cr..
• For Tax %, as of Mar 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Dec 2024) to 16.00%, marking a decrease of 10.00%.
• For Net Profit, as of Mar 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Dec 2024) to 29.00 Cr., marking a decrease of 5.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 4.56. The value appears to be declining and may need further review. It has decreased from 5.40 (Dec 2024) to 4.56, marking a decrease of 0.84.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:05 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:15 am

Below is a detailed analysis of the balance sheet data for Taj GVK Hotels & Resorts Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 615.00 Cr.. The value appears strong and on an upward trend. It has increased from 530.00 Cr. (Mar 2024) to 615.00 Cr., marking an increase of 85.00 Cr..
• For Borrowings, as of Mar 2025, the value is 44.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 108.00 Cr. (Mar 2024) to 44.00 Cr., marking a decrease of 64.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 181.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 162.00 Cr. (Mar 2024) to 181.00 Cr., marking an increase of 19.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 852.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 812.00 Cr. (Mar 2024) to 852.00 Cr., marking an increase of 40.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 433.00 Cr.. The value appears to be declining and may need further review. It has decreased from 442.00 Cr. (Mar 2024) to 433.00 Cr., marking a decrease of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2024) to 116.00 Cr., marking an increase of 37.00 Cr..
• For Investments, as of Mar 2025, the value is 110.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 110.00 Cr..
• For Other Assets, as of Mar 2025, the value is 193.00 Cr.. The value appears strong and on an upward trend. It has increased from 181.00 Cr. (Mar 2024) to 193.00 Cr., marking an increase of 12.00 Cr..
• For Total Assets, as of Mar 2025, the value is 852.00 Cr.. The value appears strong and on an upward trend. It has increased from 812.00 Cr. (Mar 2024) to 852.00 Cr., marking an increase of 40.00 Cr..

Notably, the Reserves (615.00 Cr.) exceed the Borrowings (44.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Taj GVK Hotels & Resorts Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 18.60. This value is within the healthy range. It has increased from 14.78 (Mar 24) to 18.60, marking an increase of 3.82.
• For Diluted EPS (Rs.), as of Mar 25, the value is 18.60. This value is within the healthy range. It has increased from 14.78 (Mar 24) to 18.60, marking an increase of 3.82.
• For Cash EPS (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from 14.09 (Mar 24) to 17.23, marking an increase of 3.14.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 104.46. It has increased from 87.36 (Mar 24) to 104.46, marking an increase of 17.10.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 104.46. It has increased from 87.36 (Mar 24) to 104.46, marking an increase of 17.10.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.72. It has increased from 65.07 (Mar 24) to 71.72, marking an increase of 6.65.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 24.03. This value is within the healthy range. It has increased from 21.04 (Mar 24) to 24.03, marking an increase of 2.99.
• For PBIT / Share (Rs.), as of Mar 25, the value is 21.92. This value is within the healthy range. It has increased from 18.82 (Mar 24) to 21.92, marking an increase of 3.10.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.51. This value is within the healthy range. It has increased from 16.75 (Mar 24) to 20.51, marking an increase of 3.76.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 15.13. This value is within the healthy range. It has increased from 11.87 (Mar 24) to 15.13, marking an increase of 3.26.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.69. This value is within the healthy range. It has increased from 14.79 (Mar 24) to 18.69, marking an increase of 3.90.
• For PBDIT Margin (%), as of Mar 25, the value is 33.49. This value is within the healthy range. It has increased from 32.34 (Mar 24) to 33.49, marking an increase of 1.15.
• For PBIT Margin (%), as of Mar 25, the value is 30.56. This value exceeds the healthy maximum of 20. It has increased from 28.92 (Mar 24) to 30.56, marking an increase of 1.64.
• For PBT Margin (%), as of Mar 25, the value is 28.59. This value is within the healthy range. It has increased from 25.74 (Mar 24) to 28.59, marking an increase of 2.85.
• For Net Profit Margin (%), as of Mar 25, the value is 21.09. This value exceeds the healthy maximum of 10. It has increased from 18.23 (Mar 24) to 21.09, marking an increase of 2.86.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 26.06. This value exceeds the healthy maximum of 20. It has increased from 22.72 (Mar 24) to 26.06, marking an increase of 3.34.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.89. This value is within the healthy range. It has increased from 16.92 (Mar 24) to 17.89, marking an increase of 0.97.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.07. This value is within the healthy range. It has increased from 17.35 (Mar 24) to 18.07, marking an increase of 0.72.
• For Return On Assets (%), as of Mar 25, the value is 13.32. This value is within the healthy range. It has increased from 11.33 (Mar 24) to 13.32, marking an increase of 1.99.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.11 (Mar 24) to 0.00, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has increased from 0.51 (Mar 24) to 0.52, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 1.5. It has increased from 1.09 (Mar 24) to 1.26, marking an increase of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.19, marking an increase of 0.15.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.76 (Mar 24) to 0.00, marking a decrease of 6.76.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.87 (Mar 24) to 0.00, marking a decrease of 5.87.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.24 (Mar 24) to 0.00, marking a decrease of 93.24.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.13 (Mar 24) to 0.00, marking a decrease of 94.13.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 17.02. This value is within the healthy range. It has increased from 10.20 (Mar 24) to 17.02, marking an increase of 6.82.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.72. This value is within the healthy range. It has increased from 6.75 (Mar 24) to 11.72, marking an increase of 4.97.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,925.58. It has increased from 2,397.12 (Mar 24) to 2,925.58, marking an increase of 528.46.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.51. This value exceeds the healthy maximum of 3. It has increased from 5.88 (Mar 24) to 6.51, marking an increase of 0.63.
• For EV / EBITDA (X), as of Mar 25, the value is 19.42. This value exceeds the healthy maximum of 15. It has increased from 18.17 (Mar 24) to 19.42, marking an increase of 1.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.66. This value exceeds the healthy maximum of 3. It has increased from 5.90 (Mar 24) to 6.66, marking an increase of 0.76.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 93.23 (Mar 24) to 0.00, marking a decrease of 93.23.
• For Price / BV (X), as of Mar 25, the value is 4.57. This value exceeds the healthy maximum of 3. It has increased from 4.39 (Mar 24) to 4.57, marking an increase of 0.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.66. This value exceeds the healthy maximum of 3. It has increased from 5.90 (Mar 24) to 6.66, marking an increase of 0.76.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness